首页> 外文期刊>Journal of Clinical Microbiology >Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis.
【24h】

Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis.

机译:医院CDC IV组c-2菌血症:通过随机扩增多态性DNA分析进行流行病学调查。

获取原文
           

摘要

The CDC group IV c-2 bacterium is a gram-negative bacillus rarely isolated from clinical specimens. This organism caused catheter-related bacteremia in five immunocompromised children hospitalized in two distinct wards of our institution between November 1993 and October 1994. Three patients recovered on empiric antibacterial chemotherapy combining ceftazidime and amikacin, and a fourth patient required imipenem instead of ceftazidime. The fifth patient recovered without treatment. Catheter removal was never necessary. The randomly amplified polymorphic DNA technique with three different primers was applied to nine isolates recovered by culturing blood from the five children and showed that all of the patients harbored isolates of the same genotype. The source of the outbreak could not be determined.
机译:CDC IV组c-2细菌是革兰氏阴性杆菌,很少从临床标本中分离出来。这种微生物在1993年11月至1994年10月间在我们机构两个不同病房住院的5名免疫功能低下的儿童中引起了与导管相关的菌血症。三名患者接受了头孢他啶和阿米卡星联合经验性抗菌化学疗法的康复,第四名患者需要用亚胺培南代替头孢他啶。第五名患者未经治疗而康复。从来没有必要拆除导管。将具有三种不同引物的随机扩增多态性DNA技术应用于通过培养五个孩子的血液而回收的九个分离株,结果表明所有患者都携带相同基因型的分离株。无法确定爆发的来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号